A recent phase III randomized trial found an investigational oral small-molecule GLP-1 receptor agonist significantly ...

The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 ...

Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...

(HealthDay News) — The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early type 2 diabetes ...

Engaging in more than 150 minutes of physical activity per week quadrupled the odds of reversing prediabetes to normal ...

Defenders of Medicaid cuts point to the Oregon Health Insurance Experiment to argue that the cuts won’t harm people’s health.

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

[4] Glycated hemoglobin detection with electrochemical sensing amplified by gold nanoparticles embedded N-doped graphene nanosheet. Biosensors and Bioelectronics (2016).

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...